159 related articles for article (PubMed ID: 38555735)
1. Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2.
Ao H; Song H; Li J; Wang X
Drug Deliv; 2024 Dec; 31(1):2324716. PubMed ID: 38555735
[TBL] [Abstract][Full Text] [Related]
2. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X
Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108
[TBL] [Abstract][Full Text] [Related]
3. Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing.
Ao H; Wang Z; Lu L; Ma H; Li H; Fu J; Li M; Han M; Guo Y; Wang X
J Nanobiotechnology; 2022 Mar; 20(1):137. PubMed ID: 35292036
[TBL] [Abstract][Full Text] [Related]
4. Folate-modified Annonaceous acetogenins nanosuspensions and their improved antitumor efficacy.
Hong J; Sun Z; Li Y; Guo Y; Liao Y; Liu M; Wang X
Int J Nanomedicine; 2017; 12():5053-5067. PubMed ID: 28765708
[TBL] [Abstract][Full Text] [Related]
5. Annonaceous acetogenins (ACGs) nanosuspensions based on a self-assembly stabilizer and the significantly improved anti-tumor efficacy.
Hong J; Li Y; Xiao Y; Li Y; Guo Y; Kuang H; Wang X
Colloids Surf B Biointerfaces; 2016 Sep; 145():319-327. PubMed ID: 27209384
[TBL] [Abstract][Full Text] [Related]
6. Sensitive Tumor Cell Line for Annonaceous Acetogenins and High Therapeutic Efficacy at a Low Dose for Choriocarcinoma Therapy.
Ao H; Li HW; Lu LK; Fu JX; Han MH; Guo YF; Wang XT
J Biomed Nanotechnol; 2021 Oct; 17(10):2062-2070. PubMed ID: 34706806
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy.
Hong C; Wang A; Xia J; Liang J; Zhu Y; Wang D; Zhan H; Feng C; Jiang X; Pan J; Wang J
Int J Nanomedicine; 2024; 19():2879-2888. PubMed ID: 38525007
[TBL] [Abstract][Full Text] [Related]
8. One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy.
Hong C; Liang J; Xia J; Zhu Y; Guo Y; Wang A; Lu C; Ren H; Chen C; Li S; Wang D; Zhan H; Wang J
Nanomicro Lett; 2020 Jun; 12(1):129. PubMed ID: 34138128
[TBL] [Abstract][Full Text] [Related]
9. Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy.
Hong J; Li Y; Li Y; Xiao Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():3239-53. PubMed ID: 27486323
[TBL] [Abstract][Full Text] [Related]
10. [Structure-activity relationship of annonaceous acetogenins against multidrug resistant human hepatic carcinoma cell line SMMC-7721/ADR].
Wang XN; Li X; Chen Y; Li Y
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2518-2523. PubMed ID: 28840693
[TBL] [Abstract][Full Text] [Related]
11. [Structure activity relationship of annonaceous acetogenins against multidrug resistant human lung cancer cell line A549/Taxol in vitro].
Shi YY; Miao YJ; Chen YY; Ma CY; Chen Y; Chen JW; Li X
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(10):1884-1888. PubMed ID: 28895338
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
13. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of annonaceous acetogenins in HepS and S180 xenografts bearing mice.
Chen Y; Chen JW; Xu SS; Wang Y; Li X; Cai BC; Fan NB
Bioorg Med Chem Lett; 2012 Apr; 22(8):2717-9. PubMed ID: 22446092
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and toxicity relationship of annonaceous acetogenins.
Chen Y; Chen JW; Zhai JH; Wang Y; Wang SL; Li X
Food Chem Toxicol; 2013 Aug; 58():394-400. PubMed ID: 23712095
[TBL] [Abstract][Full Text] [Related]
16. Annonaceous acetogenins mediated up-regulation of Notch2 exerts growth inhibition in human gastric cancer cells in vitro.
Li Y; Ye J; Chen Z; Wen J; Li F; Su P; Lin Y; Hu B; Wu D; Ning L; Xue Q; Gu H; Ning Y
Oncotarget; 2017 Mar; 8(13):21140-21152. PubMed ID: 28416750
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of diverse ACGs against multidrug resistant human lung cancer cell line A549/Taxol.
Yuan F; Bai G; Chen Y; Miao Y; Chen J; Li X
Bioorg Med Chem Lett; 2015 Feb; 25(4):787-90. PubMed ID: 25582602
[TBL] [Abstract][Full Text] [Related]
18. EGFR-Targeted Liposomes Combined with Ginsenoside Rh2 Inhibit Triple-Negative Breast Cancer Growth and Metastasis.
Gu H; Shi R; Xu C; Lv W; Hu X; Xu C; Pan Y; He X; Wu A; Li J
Bioconjug Chem; 2023 Jun; 34(6):1157-1165. PubMed ID: 37235785
[TBL] [Abstract][Full Text] [Related]
19. Photothermal combined with intratumoral injection of annonaceous acetogenin nanoparticles for breast cancer therapy.
Zuo C; Zou Y; Gao G; Sun L; Yu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2022 May; 213():112426. PubMed ID: 35219964
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of diverse annonaceous acetogenins against human tumor cells.
Yang H; Zhang N; Li X; Chen J; Cai B
Bioorg Med Chem Lett; 2009 Apr; 19(8):2199-202. PubMed ID: 19285863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
